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Abstract. The modern methods of blood analysis are analyzed in the article. The 
feasibility of their use for diagnosing diseases in the early stages is presented and 
investigated in the article, too. The object of the work is blood test of a human and 
the subject is methods of examining blood plasma, circulating tumor cells and 
mononuclear cells. 
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Аннотация. В работе анализируются современные методы анализа крови. А 
также целесообразность их использования для диагностики различных 
заболеваний на ранних стадиях. Объект данной работы – анализ крови 
человека, а предмет – современные методы исследования плазмы крови, 
опухолевых клеток. 
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Current relevance. There has been frequent discussion about applying 
different techniques in blood analysis suitable for all types of examination of a 
patient. The greatest controversy has centered on whether the modern methods 
should be used or not.  
Innovative methods of blood analysis in the modern world are an integral part, 
and their relevance reaches its climax in mind environmental degradation and 
socio-economic conditions, accompanied by a prolonged stressful situation, which 
leads to a decrease of immune reactivity of the population increasing frequency of 
development of secondary immune deficiencies. 
Subject and object. The object of study is human blood test. 
The subject of study is methods of examining blood plasma, circulating tumor 
cells, mononuclear cells. 
Main body. To start with, blood, fulfilling the body's most important 
metabolic functions (respiration, nutrition and excretion) is simultaneously a 
carrier of information that allows it to induce the body if there is a necessity to 
incorporate your adaptive reserves, correcting its vital functions, including the 
protection and rehabilitation of organs, systems and organism as a whole. 
Blood is a complex fluid tissue composed of a liquid portion, plasma, and 
cellular components. Plasma is a mixture of dissolved proteins, salts and other 
chemicals. The blood cells are of three main types: red blood cells, which are 
called as erythrocytes, white blood cells which are called as leukocytes and 
platelets, which are called as thrombocytes.  
The quality of the blood is immediately reflected in the haematopoiesis and 
morphological features of the cells of peripheral blood flow. These reactive states 
of morphological features of the cells of peripheral blood flow are the object of 
study and disease diagnosis in a laboratory of her research, since they reflect a 
particular pathology of the organism as an integrated living system. 
To understand the methods of examining blood, it should be stated that «a 
blood test is a laboratory analysis performed on a blood sample that is usually 
extracted from a vein in the arm using a needle, or via fingerprick. Multiple tests 
for specific blood components (such as a glucose test or a cholesterol test) are 
often grouped together into one test panel called a blood panel or blood work. 
Blood tests are often used in health care to determine physiological and 
biochemical states, such as disease, mineral content, pharmaceutical drug 
effectiveness, and organ function. Typical clinical blood panels include a basic 
metabolic panel or a complete blood count. Blood tests are also used in drug tests 
to detect drug abuse. In some of the United States, a blood test is required before 
marriage; historically, this was previously true in more states» [Wikipedia, e-doc]. 
Local and systemic changes in immunity can be detected through 
immunological study of blood using the basic traditional and modern methods. 
Immunological methods are required to create new diagnostic and therapeutic 
technologies, including pathogenetically substantiated tailored immunotherapy 
with the features of the immune system of the individual patient. Timely correct 
diagnosis of immune disorders, allowing their correction, allows reducing the dose 
and duration of use of antibiotics, to prevent the occurrence of allergic reactions. 
The main parameters of the immune status are the number and activity of 
circulating lymphocytes, natural killer and phagocytic cells, the concentration of 
serum immunoglobulin, the content of specific antibodies [Кулаков, 2009]. 
Immunological methods allow characterizing the immunological background, 
which develops the majority of gynecological and obstetrical diseases, and monitor 
the effectiveness of treatment, primarily immune modulatory drugs. 
There is quantitative determination of subpopulations of lymphocytes using 
monoclonal antibodies – antibodies that are identical because they are produced by 
one type of immune cell, all clones of a single parent cell; a single type of antibody 
that is directed against a specific antigenic determinant (epitope).  
Division of human lymphocytes to T-lymphocytes, B-lymphocytes and 
natural killer cells based on their biological functions and expression of their cell 
surface antigens (AG), determine the level which is called the full. The method is 
based on binding of fluorescent labeled monoclonal at the surface of AG 
lymphocytes and profitability analysis using laser flow cytometer or fluorescent 
microscopy. 
The aim of the study is the cell count of a particular population, or spectrum 
of AG, expressed on these cells. 
From the patient's vein, take blood in a tube with heparin (20 U/ml). The 
blood is treated with lysing solution to destruction of erythrocytes or by using a 
gradient centrifugation of the isolated fraction of mononuclear cells. The cell 
suspension is incubated in the dark for 15-30 min with the appropriate fluorescent 
labeled monoclonal at.  
The results recorded on a flow cytometer or by using a fluorescent microscope 
within 6 h. the lymphocytes were fixed with 1% paraformaldehyde can be stored at 
+2-8 °C for up to 24 h. The analysis allows to estimate the number of lymphocytes 
in subpopulations, the results are compared with standard values, calculate the ratio 
of T-helper and T-cytotoxic lymphocytes (immune regulatory index), the content 
of activated T-lymphocytes. Determination of the percentage of T-lymphocytes, b-
lymphocytes and NK-cells are used for the characterization of immunodeficiency 
and autoimmune conditions, neoplastic and viral diseases. The full cells used to 
confirm the diagnosis and monitor the condition of the immune system of the 
patient in the treatment process [Кулаков, 2009]. The sensitivity and specificity of 
the method depends on the quality of reagents used. 
There is a method for determining the activity of matrix metalloproteinases 2 
and 9 (ММP2 and ММP9) in serum (zymography). Expression ММP2 and ММP9 
in the tissue reflect the processes of tissue remodeling in both normal 
(menstruation, ovulation, implantation), and pathology (inflammatory and 
hyperplastic processes, fibrosis). ММP2, ММP9 tissue and penetrate into the 
blood in concentrations proportional to their expression in tissues. Measuring their 
concentration in serum gives information about the status of tissue reconstruction 
and allows assessing the dynamics of the manifestations of the pathological 
process and the effectiveness of treatment [Савельева, 2009]. 
The aim of the study is the diagnosis of inflammatory and hyperplastic 
processes in the female reproductive system and monitoring the flow and 
effectiveness of treatment. It is necessary to mention, that female reproductive 
system is very complicated. It «contains two main parts: the uterus, which acts as 
the receptacle for the male'ssperm, and the ovaries, which produce the female's egg 
cells. These parts are internal; the vagina meets the externalorgans at the vulva, 
which includes the labia, clitoris and urethra. The vagina is attached to the uterus 
through thecervix, while the uterus is attached to the ovaries via the Fallopian 
tubes. At certain intervals, the ovaries release anovum, which passes through the 
Fallopian tube into the uterus» [FRS, 2010]. Thus, its testing need careful and 
attentive analysis of blood and its components.  
The blood plasma is separate of venous blood which is explored in such kind 
of testing. Serum samples applied to polyacrylamide gel, containing a substrate for 
ММP2 and ММP9, whey proteins are separated under the action of electric 
current. Next, the gel is incubated, while being in it ММP2 and ММP9 destroy the 
substrate. Next, the gel is incubated, while being in it ММP2 and ММP9 destroy 
the substrate. These bands correspond in these areas ММP2 and ММP9. The 
colour intensity of the bands is proportional to concentration ММP2 and ММP9 
[Савельева, 2009]. 
Equally important is the analysis of circulating tumor cells (CTC) in the 
blood. «Circulating tumor cells are cells that have shed into the vasculature or 
lymphatics from a primary tumor and are carried around the body in 
the circulation. CTCs thus constitute seeds for the subsequent growth of additional 
tumors (metastases) in vital distant organs, triggering a mechanism that is 
responsible for the vast majority of cancer-related deaths» [Wikipedia, e-doc].  
Today more than 1 million people is treated from cancer in Ukraine. Every 
year doctors record 160-200 thousand new cases of the disease. Every day 450 
people in Ukraine know that had cancer, and this statistic continues to grow. More 
than 30% of all cancer cases are diagnosed at later stages. Diagnosis of the disease 
in the early stages, it is fast and quality of healing [Колесник, 2016]. 
Cancer is the uncontrolled growth of cells in the body. Over the past several 
decades, the realizing of cancer has improved a lot. «Cancer is an extremely 
complex disease composed of various molecular alterations and phenotypic 
changes. The vast majority of cancer deaths occur due to metastasis of the primary 
tumor to distant sites via circulating tumor cells in the circulation. Circulating 
tumor cells are extremely rare. Over the past 5–10 years, various methodologies 
and platforms have been developed to isolate circulating tumor cells for further 
characterization and molecular analyses. The emergence of these technologies 
have spurred a great interest in circulating tumor cells and researchers and 
clinicians are realizing the importance of circulating tumor cells in cancer biology 
as well as their use in cancer diagnosis and therapy» [NDR]. 
The aim of the circulating tumor cells study is to determine the presence of 
tumor cells circulating in the blood. 
The analysis of circulating tumor cells allows you to recognize cancer cells, 
their number and even able to identify the type of cancer much earlier than existing 
imaging systems such as positron emission tomography (PET/CT), magnetic 
resonance imaging (MRI), computed tomography (CT) or ultrasonography (us). 
The analysis of circulating tumor cells is able to recognize cancer cells in the blood 
when tumor size 0.5 mm [Балоглу, 2016]. 
The technique allows carrying out accurate and early detection of cancer cells. 
Scientific data show that the tumor cells penetrate into the bloodstream before the 
tumor is still very small. This technology distinguishes these cells from the blood, 
identifies with specific antibodies (monoclonal antibodies to epithelial antigens. 
The system can detect one tumor cell among a billion blood cells. Any change in 
the number of tumor cells in blood provides doctors with unique information on 
the progress of the disease at a very early stage. 
In order to analyze circulating tumor cells, you need 10 ml of blood. The 
technology of drawing blood requires a rejection of the first 2 ml, to epithelial cells 
at the puncture site did not affect the accuracy of the analysis. This new method 
recognizes the tumor cells, determining their number and identificeret type of 
cancer. All these steps can be done in just 1 day.  
The analysis of circulating tumor cells recognizes epithelial tumors, which 
account for 90% of all echnologically diseases. The technique with 100% accuracy 
identifies 5 sources of circulating tumor cells in lung cancer, breast cancer, 
colorectal cancer, thyroid cancer, prostate cancer. 
The analysis of circulating tumor cells gives absolutely precise data for 
epithelial tumours, is more than 0, 5 mm, since ultra-small tumors still do not 
allocate cells in the blood. A major advantage of the technique is that it does not 
give falsely positive diagnoses, i.e. the patient will never say that he has cancer, if 
his body there [Балоглу, 2016]. 
This innovative method allows us to trace the process of treatment of each 
patient. Using existing methods of diagnosis of cancer, such as PET/CT, the 
treatment outcome can be assessed only after 3 months, while subjecting the 
patient to radiation. The analysis of circulating tumor cells after 2 weeks of therapy 
gives accurate information about the change in the number of tumor cells before 
and after treatment. The analysis of circulating tumor cells enables oncologists 
routinely and quickly analyze whether the acts prescribed therapy and, if the result 
is positive, continue to monitor. 
Conclusion. Blood is a source of information about a human in general and 
about his / her health in particular. It is a key to patient’s treatment. It should be 
mentioned, that there are many modern types of blood test which are applied in 
medicine to treat different diseases. Innovative analysis of blood provides the 
opportunity for timely and correct diagnosis of various diseases: neoplastic, viral, 
immunodeficiency and autoimmune states. Early diagnosis allows carrying out 
quick and quality treatment of these diseases. 
This information can be used for theoretical use in learning hematology, for 
practical use in work with testing blood. Thus, it can be used as the material for 
developing knowledge in blood and its analysis for medical students, interns and 
junior practitioners. 
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